openPR Logo
Press release

Sciatica Pipeline Overview 2024: FDA Approvals, Analysis of Clinical Trials, Therapies, MOA, ROA, and Developments by DelveInsight | Regeneron Pharma, Breath of Life International Pharma, Medtronic, Cephalon, Biogen

01-15-2025 08:03 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Sciatica Pipeline Overview 2024: FDA Approvals, Analysis

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sciatica pipeline constitutes 5+ key companies continuously working towards developing 5+ Sciatica treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Sciatica Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Sciatica Market.

The Sciatica Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Sciatica Pipeline Report: https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Sciatica treatment therapies with a considerable amount of success over the years.
• Sciatica companies working in the treatment market are Regeneron Pharma, Breath of Life International Pharma, Medtronic, Cephalon, Biogen, Johnson & Johnson, and others, are developing therapies for the Sciatica treatment
• Emerging Sciatica therapies in the different phases of clinical trials are- REGN475, BOL-DP-o-04 + SCO, MDT-15, CEP-37247, BG00010, CG 5503, and others are expected to have a significant impact on the Sciatica market in the coming years.
• In November 2024, Contineum Therapeutics, Inc. (NASDAQ: CTNM), a clinical-stage biopharmaceutical company dedicated to developing innovative oral small molecule therapies for neuroscience, inflammation, and immunology (NI&I) conditions, announced that the U.S. Food and Drug Administration (FDA) has authorized its Investigational New Drug (IND) application for PIPE-791. This novel, brain-penetrant small molecule antagonist of the lysophosphatidic acid 1 receptor (LPA1R) is being developed to treat chronic pain associated with osteoarthritis (OA) and low back pain (LBP).

Sciatica Overview
Sciatica is a term used to describe pain that radiates along the sciatic nerve, which runs from the lower back through the hips and buttocks and down each leg. It typically occurs when the sciatic nerve is compressed or irritated, often due to a herniated disc, bone spurs, or spinal stenosis. Sciatica is characterized by sharp, shooting pain, numbness, or tingling sensations, and it can affect one side of the body. It may also be accompanied by weakness in the affected leg. The condition often improves with conservative treatments like rest, physical therapy, and pain management, though in some cases, surgery may be required.

Get a Free Sample PDF Report to know more about Sciatica Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Sciatica Drugs Under Different Phases of Clinical Development Include:
• REGN475: Regeneron Pharma
• BOL-DP-o-04 + SCO: Breath of Life International Pharma
• MDT-15: Medtronic
• CEP-37247: Cephalon
• BG00010: Biogen
• CG 5503: Johnson & Johnson

Sciatica Route of Administration
Sciatica pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Sciatica Molecule Type
Sciatica Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Sciatica Pipeline Therapeutics Assessment
• Sciatica Assessment by Product Type
• Sciatica By Stage and Product Type
• Sciatica Assessment by Route of Administration
• Sciatica By Stage and Route of Administration
• Sciatica Assessment by Molecule Type
• Sciatica by Stage and Molecule Type

DelveInsight's Sciatica Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Sciatica product details are provided in the report. Download the Sciatica pipeline report to learn more about the emerging Sciatica therapies at:
https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Sciatica Therapeutics Market include:
Key companies developing therapies for Sciatica are - Sinfonia Biotherapeutics, Seikagaku, Kolon Life Science, Sorrento Therapeutics, SpineThera, Eliem Therapeutics, Scilex Holding, Vita Sciences, Aurobindo Pharma, and others.

Sciatica Pipeline Analysis:
The Sciatica pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Sciatica with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Sciatica Treatment.
• Sciatica key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Sciatica Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Sciatica market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Sciatica drugs and therapies- https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Sciatica Pipeline Market Drivers
• Rising prevalence of musculoskeletal disorders, Aging population, Advancements in treatment options, Increased awareness, Growing demand for non-surgical treatments, Improvement in diagnostic technologies, are some of the important factors that are fueling the Sciatica Market.

Sciatica Pipeline Market Barriers
• However, High cost of advanced treatments, Lack of standardized treatment guidelines, Limited long-term data on treatment effectiveness, Side effects and complications, Difficulty in achieving accurate diagnosis, Reimbursement issues, and other factors are creating obstacles in the Sciatica Market growth.

Scope of Sciatica Pipeline Drug Insight
• Coverage: Global
• Key Sciatica Companies: Regeneron Pharma, Breath of Life International Pharma, Medtronic, Cephalon, Biogen, Johnson & Johnson, and others
• Key Sciatica Therapies: REGN475, BOL-DP-o-04 + SCO, MDT-15, CEP-37247, BG00010, CG 5503, and others
• Sciatica Therapeutic Assessment: Sciatica current marketed and Sciatica emerging therapies
• Sciatica Market Dynamics: Sciatica market drivers and Sciatica market barriers

Request for Sample PDF Report for Sciatica Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Sciatica Report Introduction
2. Sciatica Executive Summary
3. Sciatica Overview
4. Sciatica- Analytical Perspective In-depth Commercial Assessment
5. Sciatica Pipeline Therapeutics
6. Sciatica Late Stage Products (Phase II/III)
7. Sciatica Mid Stage Products (Phase II)
8. Sciatica Early Stage Products (Phase I)
9. Sciatica Preclinical Stage Products
10. Sciatica Therapeutics Assessment
11. Sciatica Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Sciatica Key Companies
14. Sciatica Key Products
15. Sciatica Unmet Needs
16 . Sciatica Market Drivers and Barriers
17. Sciatica Future Perspectives and Conclusion
18. Sciatica Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Sciatica Market https://www.delveinsight.com/report-store/sciatica-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Sciatica Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Sciatica Epidemiology https://www.delveinsight.com/report-store/sciatica-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Sciatica Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
• Post Menopausal Osteoporosis Market: https://www.delveinsight.com/report-store/post-menopausal-osteoporosis-pipeline-insight
• HiPost Menopausal Osteoporosis Market: https://www.delveinsight.com/report-store/post-menopausal-osteoporosis-pipeline-insight
• Hip Replacement Devices Market: https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
• Amblyopia Market: https://www.delveinsight.com/report-store/amblyopia-market
• Type 2 Diabetes Market: https://www.delveinsight.com/report-store/diabetes-market
• Parp Poly Adp-ribose Polymerase Inhibitor Market: https://www.delveinsight.com/report-store/poly-adp-ribose-polymerase-1-parp-inhibitor-pipeline-insight

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sciatica Pipeline Overview 2024: FDA Approvals, Analysis of Clinical Trials, Therapies, MOA, ROA, and Developments by DelveInsight | Regeneron Pharma, Breath of Life International Pharma, Medtronic, Cephalon, Biogen here

News-ID: 3816741 • Views:

More Releases from DelveInsight Business Research

Glaucoma Drugs Market 2034: Clinical Trials, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight | Bayer, SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire Pharma
Glaucoma Drugs Market 2034: Clinical Trials, Prevalence, Incidence, Therapies, E …
(Albany, USA) DelveInsight's "Glaucoma Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as well as the Glaucoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Glaucoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Glaucoma Market Forecast https://www.delveinsight.com/sample-request/glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr Some of the key facts of the Glaucoma
Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA and Companies by DelveInsight
Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, …
(Albany, United States) DelveInsight's, "Urothelial Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 40+ Urothelial Carcinoma companies and 50+ pipeline drugs in the Urothelial Carcinoma pipeline landscape. It covers the Urothelial Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Urothelial Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this
Uveitis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA and Companies by DelveInsight
Uveitis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, Uveitis pipeline constitutes 15+ key companies continuously working towards developing 15+ Uveitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Uveitis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Uveitis Market. The Uveitis Pipeline report embraces in-depth commercial and clinical assessment of the
X-Linked Retinitis Pigmentosa Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA and Companies by DelveInsight
X-Linked Retinitis Pigmentosa Clinical Trials 2025: EMA, PDMA, FDA Approvals, Me …
(Albany, United States) As per DelveInsight's assessment, globally, the X-Linked Retinitis Pigmentosa Pipeline constitutes 5+ key companies continuously working towards developing 5+ X-Linked Retinitis Pigmentosa Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight. In the X-Linked Retinitis Pigmentosa Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, X-Linked Retinitis

All 5 Releases


More Releases for Sciatica

Sciatica Treatment Market, Market Drivers, Market Barriers, Emerging Drugs and M …
DelveInsight's Sciatica Market Insights report provides a thorough understanding of current treatment practices, emerging Sciatica market share of the individual therapies, current and forecasted Sciatica Market size from 2018 to 2030 segmented into 7MM (the USA, EU5 (the UK, Italy, Spain, France, and Germany), and Japan). Sciatica Overview Sciatica is a specific pain in the lower extremity resulting from irritation of the sciatic nerve-direct result of the sciatic nerve or sciatic nerve
Sciatica Disease Market Report- Demand, Cost Structures, Latest trends, and Fore …
The Sciatica Disease Market research report assists in deciding and optimizing each stage in the lifecycle of the industrial process that incorporates acquisition, includes engagement, monetization, and retention. To develop this all-inclusive Sciatica Disease Market research report, the market experts and analysts have studied and monitored various market factors and products. Sciatica Disease Market also offered significant factors that are likely to drive the market or restrain it during
Sciatica Treatment Market May See a Big Move : Major Giants AstraZeneca, Pfizer, …
Sciatica Treatment Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Sciatica Treatment industry with an attention on the Global market. The report gives key insights available status of the Sciatica Treatment producers and is an important wellspring of direction and course for organizations and people keen on the business. By and large, the report gives an inside and out understanding
Sciatica Pipeline Market Insight 2020, Key Players, Products, Symptoms and Diagn …
“Sciatica - Pipeline Insight, 2020” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Sciatica pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global coverage Key Players - Breath of Life International Pharma - Biogen - Renovis - Regeneron
Sciatica Treatment Market is Likely to Register Double Digit CAGR During 2017 …
Irritation of the sciatic nerve causes pain in the lower portion of the body. This pain is termed as sciatica pain. Sciatica pain usually starts from the lumbar area of the body (lower back portion) to backwards of the thigh. It can also reach below the knee. Sciatic nerve is the largest nerve in a human body. Sciatic nerve starts from nerve origins of the lumbar spinal cord in the
Sciatica Treatment Market Set to Record Exponential Growth by 2025
Irritation of the sciatic nerve causes pain in the lower portion of the body. This pain is termed as sciatica pain. Sciatica pain usually starts from the lumbar area of the body (lower back portion) to backwards of the thigh. It can also reach below the knee. Sciatic nerve is the largest nerve in a human body. Sciatic nerve starts from nerve origins of the lumbar spinal cord in the